Showing results (371-380 of 563) with videos related to

Sort By:
Pageof 57
Molecular Oncology|March 25, 2014
Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cellsMylène A Carrascal, Paulo F Severino, M Guadalupe Cabral, et al.
Frontiers in Bioengineering and Biotechnology|January 27, 2025
Therapeutic functions of medical implants from various material categories with integrated biomacromolecular systemsGuilherme Bedeschi Calais, Guilherme Domingos Garcia, Celso Fidelis de Moura Júnior, et al.
The Lancet. Public Health|July 29, 2023
Non-communicable disease mortality in young people with a history of contact with the youth justice system in Queensland, Australia: a retrospective, population-based cohort studyLucas Calais-Ferreira, Jesse T Young, Kate Francis, et al.
The Prostate|November 29, 2022
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meetingAndrea K Miyahira, Jessica E Hawley, Remi Adelaiye-Ogala, et al.
European Urology|March 17, 2024
Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical TrialJohn Nikitas, Matthew Rettig, John Shen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 21, 2015
Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)Marieke L Fokkema, Stefan K James, Per Albertsson, et al.
Frontiers in Medicine|June 26, 2020
Correlation Between FDG Hotspots on Pre-radiotherapy PET/CT and Areas of HNSCC Local Relapse: Impact of Treatment Position and Images Registration MethodBlandine Truffault, David Bourhis, Anne Chaput, et al.
Jornal Brasileiro De Nefrologia|January 10, 2025
Collapsing glomerulopathy associated with parvovirus B19 and systemic lupus erythematosus in a patient with APOL1 high-risk variant for nephropathyThaíza Passaglia Bernardes, Thalita Alvarenga Ferradosa Paula, Gabriel Teixeira Montezuma Sales, et al.
Scientific Reports|October 17, 2024
Phase 2 trial of PSMA PET CT versus planar bone scan and CT in prostate cancer patients progressing while on androgen deprivation therapyJohn Nikitas, Andrei Gafita, Matthias R Benz, et al.
EJNMMI Research|October 1, 2022
Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225Catherine Meyer, Vikas Prasad, Andreea Stuparu, et al.
Pageof 57